Literature DB >> 26762877

T1 Mapping: Basic Techniques and Clinical Applications.

Andrew J Taylor1, Michael Salerno2, Rohan Dharmakumar3, Michael Jerosch-Herold4.   

Abstract

In cardiac magnetic resonance (CMR) imaging, the T1 relaxation time for the 1H magnetization in myocardial tissue may represent a valuable biomarker for a variety of pathological conditions. This possibility has driven the growing interest in quantifying T1, rather than just relying on its effect on image contrast. The techniques have advanced to where pixel-level myocardial T1 mapping has become a routine component of CMR examinations. Combined with the use of contrast agents, T1 mapping has led an expansive investigation of interstitial remodeling in ischemic and nonischemic heart disease. The purpose of this review was to introduce the reader to the physical principles of T1 mapping, the imaging techniques developed for T1 mapping, the pathophysiological markers accessible by T1 mapping, and its clinical uses.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  fibrosis; interstitium; magnetic resonance imaging; myocardium

Mesh:

Substances:

Year:  2016        PMID: 26762877     DOI: 10.1016/j.jcmg.2015.11.005

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  127 in total

Review 1.  Cardiac MRI for the evaluation of oncologic cardiotoxicity.

Authors:  Adrián I Löffler; Michael Salerno
Journal:  J Nucl Cardiol       Date:  2018-05-07       Impact factor: 5.952

Review 2.  Recent Advances in Cardiovascular Magnetic Resonance: Techniques and Applications.

Authors:  Michael Salerno; Behzad Sharif; Håkan Arheden; Andreas Kumar; Leon Axel; Debiao Li; Stefan Neubauer
Journal:  Circ Cardiovasc Imaging       Date:  2017-06       Impact factor: 7.792

3.  Black-blood native T1 mapping: Blood signal suppression for reduced partial voluming in the myocardium.

Authors:  Sebastian Weingärtner; Nadja M Meßner; Frank G Zöllner; Mehmet Akçakaya; Lothar R Schad
Journal:  Magn Reson Med       Date:  2016-09-16       Impact factor: 4.668

4.  Accurate and robust systolic myocardial T1 mapping using saturation recovery with individualized delay time: comparison with diastolic T1 mapping.

Authors:  Hideo Arai; Masateru Kawakubo; Kenichi Sanui; Hiroshi Nishimura; Toshiaki Kadokami
Journal:  Radiol Phys Technol       Date:  2018-09-24

5.  Diagnostic Performance of Extracellular Volume, Native T1, and T2 Mapping Versus Lake Louise Criteria by Cardiac Magnetic Resonance for Detection of Acute Myocarditis: A Meta-Analysis.

Authors:  Jonathan A Pan; Yoo Jin Lee; Michael Salerno
Journal:  Circ Cardiovasc Imaging       Date:  2018-07       Impact factor: 7.792

Review 6.  The role of imaging in pulmonary hypertension.

Authors:  Meenal Sharma; Andrew T Burns; Kelvin Yap; David L Prior
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

7.  Identification of cardiovascular abnormalities by multiparametric magnetic resonance imaging in end-stage renal disease patients with preserved left ventricular ejection fraction.

Authors:  Ling Lin; Qiuxia Xie; Mei Zheng; Xuhui Zhou; Ilona A Dekkers; Qian Tao; Hildo J Lamb
Journal:  Eur Radiol       Date:  2021-02-24       Impact factor: 5.315

8.  Assessment of myocardial fibrosis using T1-mapping and extracellular volume measurement on cardiac magnetic resonance imaging for the diagnosis of radiation-induced cardiomyopathy.

Authors:  Natsuko Mukai-Yatagai; Nobuhiko Haruki; Yoshiharu Kinugasa; Yasutoshi Ohta; Hatsue Ishibashi-Ueda; Toshihiko Akasaka; Masahiko Kato; Toshihide Ogawa; Kazuhiro Yamamoto
Journal:  J Cardiol Cases       Date:  2018-06-30

Review 9.  Myocardial T1 and ECV Measurement: Underlying Concepts and Technical Considerations.

Authors:  Austin A Robinson; Kelvin Chow; Michael Salerno
Journal:  JACC Cardiovasc Imaging       Date:  2019-09-18

10.  Inflammation and Fibrosis in HIV: Getting to the Heart of the Matter.

Authors:  Priscilla Y Hsue; Ahmed Tawakol
Journal:  Circ Cardiovasc Imaging       Date:  2016-03       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.